Company
Roche
Roche Holding AG
Public (SIX:ROG) · Basel, Switzerland · Last verified Aug 15, 2024
Swiss pharma/biotech that acquired Carmot Therapeutics to add oral and injectable incretin assets.
Company profile
- Legal name
- Roche Holding AG
- Status
- public
- Ticker
- SIX:ROG
- Headquarters
- Basel, Switzerland
- Website
- www.roche.com
Active assets
| Asset | Stage | Indications |
|---|---|---|
| CT-388 | Phase 1 | — |
Trial roll-up
View all →| Registry ID | Phase | Title | Status |
|---|---|---|---|
| Roche-CT388-Ph1 | Phase 1 | A Study of CT-388 in Participants With Obesity or Overweight | Recruiting |
Deals
View all →| Parties | Type | Headline value | Announced |
|---|---|---|---|
| Roche Holding AG / Carmot Therapeutics Inc. | acquisition | $3.1 billion (contingent) | Dec 4, 2023 |